Insulin and Glucagon Regulate Cytosolic Phosphoenolpyruvate Carboxykinase (GTP) mRNA in Rat Liver
The DOI matches its Crossref record.
Abstract
Insulin causes a 7–10-fold decrease of both the mRNA that codes for rat hepatic phosphoenolpyruvate carboxykinase (mRNAPEPCK) and of PEPCK synthesis, provided the animals are made diabetic and fed chow. mRNAPEPCK, measured either by in vitro translation or cDNA hybridization, decreases with a half-time of 30–60 min after insulin treatment. This coordinant decrease, which approximates the half-life of mRNAPEPCK measured in a variety of situations, suggests that insulin acts by decreasing mRNAPEPCK production, and that the hormone does not alter the activity of a fixed amount of this RNA, or enhance its degradation. Glucagon results in a ninefold induction of mRNAPEPCK. Half-maximal induction occurs with doses between 20–75 μg/100 g body wt and occurs within 30–45 min. Maximal induction requires 150 μg/100 g body wt and occurs about 80 min after a single glucagon injection. N6,O2' -dibutyryl cAMP and a cAMP analogue that is not metabolized, 8-(4-chlorophenylthio)cAMP, induce mRNAPEPCK as effectively as glucagon and with similar kinetics. Since sodium butyrate, adenosine, and dibutyryl cGMP are ineffective inducers, cAMP appears to be the active agent in the hepatocyte.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
“Fructose-1,6-bisphosphatase (FBPase-1) catalyzes the hydrolysis of the C-1 phosphate in fructose-1,6bisphosphate [F(1,6)P2], converting F(1,6)P2 into fructose 6-phosphate (F-6-P), an important step in gluconeogenesis (Fig.”
BackgroundInfluentialThe New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“Second, glucagon increases mRNA levels of PEPCK (44, 102, 312) via the PKA-CREB-CRTC2 pathway.”
BackgroundGlucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice
Lee, Y., Wang, M.-Y., Du, X. Q., Charron, M. J., & Unger, R. H. (2011) · Diabetes · doi:10.2337/db10-0426 · Cited by 327
“To assess the completeness of glucagon inactivation in the Gcgr mice, we compared the hepatic levels of P-CREB (27), a key protein in its signal transduction pathway, with those of wild-type controls.”
MethodInfluentialNeural connections between the hypothalamus and the liver
Uyama, N., Geerts, A., & Reynaert, H. (2004) · The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology · doi:10.1002/ar.a.20086 · Cited by 201
Hepatic glucose metabolism in humans—its role in health and disease
Roden, M., & Bernroider, E. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00031-9 · Cited by 201
Metadata
- Authors
- Beale, E., Andreone, T., Koch, S., Granner, M., & Granner, D.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1984-04-01
- Volume
- 33
- Issue
- 4
- Pages
- 328-332
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1977804359
- Cited by
- 69
- References
- 0
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Insulin and Glucagon Regulate Cytosolic Phosphoenolpyruvate Carboxykinase (GTP) mRNA in Rat Liver. https://app.cochat.ai/papers/10.2337/diab.33.4.328
- The paper
- Beale, E., Andreone, T., Koch, S., Granner, M., & Granner, D. (1984). Insulin and Glucagon Regulate Cytosolic Phosphoenolpyruvate Carboxykinase (GTP) mRNA in Rat Liver. Diabetes. https://doi.org/10.2337/diab.33.4.328
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.